Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: autophagy

February 19, 2026 CD as API / Drug delivery / Pharma applications

Enhancing the Water Solubility and Efficacy of Anticancer Drugs Using Hydroxypropyl-β-Cyclodextrin

Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with

Continue reading

January 27, 2026 CD as API / Pharma applications

A water-soluble β-cyclodextrin polymer reduces cholesterol accumulation and autophagy dysfunction in vitro and in Niemann-Pick type C disease model mice

A β-CDP (CycloLab) was used for the experiments. The purity of the β-CDP was >95 %. The β-CDP contained <1 % of

Continue reading

a rat is standing on top of a plastic container
November 24, 2025 CD as API / CD derivatives / Pharma applications

A β-cyclodextrin polymer reduces cholesterol accumulation and mitigates autophagy dysfunction in vitro and in a Niemann–Pick Type C animal model

Niemann–Pick disease type C (NPC) and Alzheimer’s disease (AD) are both characterised by cognitive decline and neurological impairment. In each

Continue reading

December 12, 2024 CD as API / Pharma applications

Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease

This noticable mini review was published in the last year but worth not to overlook as it is in line

Continue reading

July 8, 2024 CD as API / Drug delivery / Pharma applications

Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

Aging is a complex and time-dependent decline in physiological function that affects most organisms, leading to increased risk of age-related

Continue reading

December 19, 2023 CD as API / CD derivatives / Pharma applications

Mannose-methyl-β-cyclodextrin suppresses tumor growth by targeting both colon cancer cells and tumor-associated macrophages

Methylated β-cyclodextrin (MβCD) can extract cholesterol from lipid rafts and induce apoptosis in cancer cells by inhibiting activation of the

Continue reading

November 27, 2023 Life sciences

Differences in the Intracellular Localization of Methylated β-Cyclodextrins-Threaded Polyrotaxanes Lead to Different Cellular States

Activation of autophagy represents a potential therapeutic strategy for the treatment of diseases that are caused by the accumulation of

Continue reading

February 21, 2023 CD as API / Pharma applications

Parkinson’s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-β-Cyclodextrin Treatment

Parkinson-disease-patient-derived cells presented differences in their energetic profile, imbalanced proliferation, apoptosis, mitophagy, and a reduced differentiation efficiency to tyrosine hydroxylase

Continue reading

February 3, 2023 CD as API / CD derivatives / Pharma applications

Mannose-modified methyl-β-cyclodextrin suppresses tumor growth

Methylated β-cyclodextrin (MeβCD) can extract cholesterol from lipid rafts and induce apoptosis in cancer cells by inhibiting activation of the

Continue reading

July 28, 2022 Drug delivery / Pharma applications

Cellular Effects of Cyclodextrins: Studies on Caco-2 and HeLa Cells

In this work the cellular internalization and the intracellular effects of (2-hydroxypropyl)-beta (HPBCD) and random methyl-beta cyclodextrin (RAMEB) on Caco-2

Continue reading

Posts pagination

1 2 Next Posts»

Recent Posts

  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Special issue: Novel macrocycles: from synthesis to supramolecular function
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer’s disease

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (67)
  • CD as API (347)
  • CD derivatives (411)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (793)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (223)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (401)
  • Other industrial use (106)
  • Pharma applications (1,186)
  • Supramolecular systems (40)
  • Uncategorized (149)

Top Posts

  • A Cyclodextrin Surprise in a Japanese Supplement
  • Modifying the interior cavity of cyclodextrin
  • Environment-Sensitive Fluorophores Report on Structural Organization of Biological Membranes at Various Depths
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease
  • How air fresheners work?
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...